Histamine in the regulation of wakefulness
- PMID: 20851648
- PMCID: PMC3016451
- DOI: 10.1016/j.smrv.2010.06.004
Histamine in the regulation of wakefulness
Abstract
The histaminergic system is exclusively localized within the posterior hypothalamus with projection to almost all the major regions of the central nervous system. Strong and consistent evidence exist to suggest that histamine, acting via H₁ and/or H₃ receptor has a pivotal role in the regulation of sleep-wakefulness. Administration of histamine or H₁ receptor agonists induces wakefulness, whereas administration of H₁ receptor antagonists promotes sleep. The H₃ receptor functions as an auto-receptor and regulates the synthesis and release of histamine. Activation of H₃ receptor reduces histamine release and promotes sleep. Conversely, blockade of H₃ receptor promotes wakefulness. Histamine release in the hypothalamus and other target regions is highest during wakefulness. The histaminergic neurons display maximal activity during the state of high vigilance, and cease their activity during non-rapid eye movement (NREM) and rapid eye movement (REM) sleep. The cerebrospinal levels of histamine are reduced in diseased states where hypersomnolence is a major symptom. The histamine deficient L-histidine decarboxylase knockout (HDC KO) mice display sleep fragmentation and increased REM sleep during the light period along with profound wakefulness deficit at dark onset, and in novel environment. Similar results have been obtained when histamine neurons are lesioned. These studies strongly implicate the histaminergic neurons of the TMN to play a critical role in the maintenance of high vigilance state during wakefulness.
Published by Elsevier Ltd.
Figures



Similar articles
-
Histamine-1 receptor is not required as a downstream effector of orexin-2 receptor in maintenance of basal sleep/wake states.Acta Physiol (Oxf). 2010 Mar;198(3):287-94. doi: 10.1111/j.1748-1716.2009.02032.x. Epub 2009 Aug 20. Acta Physiol (Oxf). 2010. PMID: 19694625 Free PMC article.
-
Altered sleep-wake characteristics and lack of arousal response to H3 receptor antagonist in histamine H1 receptor knockout mice.Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4687-92. doi: 10.1073/pnas.0600451103. Epub 2006 Mar 13. Proc Natl Acad Sci U S A. 2006. PMID: 16537376 Free PMC article.
-
The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders.Biochem Pharmacol. 2007 Apr 15;73(8):1157-71. doi: 10.1016/j.bcp.2007.01.002. Epub 2007 Jan 7. Biochem Pharmacol. 2007. PMID: 17288995
-
[Regulation of the phases of the sleep-wakefulness cycle with histamine].Rev Neurol. 2017 Mar 16;64(6):267-277. Rev Neurol. 2017. PMID: 28272728 Review. Spanish.
-
[Advances in the study of histaminergic systems and sleep-wake regulation].Yao Xue Xue Bao. 2011 Mar;46(3):247-52. Yao Xue Xue Bao. 2011. PMID: 21626776 Review. Chinese.
Cited by
-
Microstructural changes in the inferior tuberal hypothalamus correlate with daytime sleepiness in Lewy body disease.medRxiv [Preprint]. 2024 Aug 16:2024.08.16.24312102. doi: 10.1101/2024.08.16.24312102. medRxiv. 2024. Update in: Mov Disord. 2025 May 30. doi: 10.1002/mds.30244. PMID: 39185524 Free PMC article. Updated. Preprint.
-
Prevalence of Diamine Oxidase Enzyme (DAO) Deficiency in Subjects with Insomnia-Related Symptoms.J Clin Med. 2024 Aug 6;13(16):4583. doi: 10.3390/jcm13164583. J Clin Med. 2024. PMID: 39200725 Free PMC article.
-
The Arousal-motor Hypothesis of Dopamine Function: Evidence that Dopamine Facilitates Reward Seeking in Part by Maintaining Arousal.Neuroscience. 2022 Sep 1;499:64-103. doi: 10.1016/j.neuroscience.2022.07.008. Epub 2022 Jul 16. Neuroscience. 2022. PMID: 35853563 Free PMC article.
-
The neurobiological basis of sleep: Insights from Drosophila.Neurosci Biobehav Rev. 2018 Apr;87:67-86. doi: 10.1016/j.neubiorev.2018.01.015. Epub 2018 Jan 31. Neurosci Biobehav Rev. 2018. PMID: 29391183 Free PMC article. Review.
-
Occurrence of sleep-related breathing disorders in patients with chronic urticaria at its asymptomatic or oligosymptomatic stages.Postepy Dermatol Alergol. 2016 Feb;33(1):63-7. doi: 10.5114/pdia.2015.48052. Epub 2016 Feb 29. Postepy Dermatol Alergol. 2016. PMID: 26985182 Free PMC article.
References
-
- Aston-Jones G. Brain structures and receptors involved in alertness. Sleep Med. 2005 Jun;6 Suppl 1:S3–S7. - PubMed
-
- Steriade M, McCarley RW. Brain Control of Sleep and Wakefulness. New York: Kluwer-Elsevier; 2005.
-
- Jones BE. From waking to sleeping: neuronal and chemical substrates. Trends Pharmacol Sci. 2005 Nov;26(11):578–586. - PubMed
-
- Monti JM. The role of dorsal raphe nucleus serotonergic and non-serotonergic neurons, and of their receptors, in regulating waking and rapid eye movement (REM) sleep. Sleep Med Rev. 2010 Feb 11; - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials